CN104450818B - A kind of method and its application that pyrroles's acid compound is prepared using hickory chick - Google Patents
A kind of method and its application that pyrroles's acid compound is prepared using hickory chick Download PDFInfo
- Publication number
- CN104450818B CN104450818B CN201410679109.2A CN201410679109A CN104450818B CN 104450818 B CN104450818 B CN 104450818B CN 201410679109 A CN201410679109 A CN 201410679109A CN 104450818 B CN104450818 B CN 104450818B
- Authority
- CN
- China
- Prior art keywords
- methanol
- acid compound
- gel column
- pyrrole
- antioxidant activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 41
- 239000002253 acid Substances 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 20
- 241000723418 Carya Species 0.000 title claims abstract 4
- 150000003233 pyrroles Chemical class 0.000 title 1
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims abstract description 38
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 32
- 238000000855 fermentation Methods 0.000 claims abstract description 14
- 230000004151 fermentation Effects 0.000 claims abstract description 14
- 238000000605 extraction Methods 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 11
- 239000001963 growth medium Substances 0.000 claims abstract description 9
- 240000002769 Morchella esculenta Species 0.000 claims abstract description 8
- 235000002779 Morchella esculenta Nutrition 0.000 claims abstract description 8
- 238000000926 separation method Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000000746 purification Methods 0.000 claims abstract description 6
- 238000004321 preservation Methods 0.000 claims abstract description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 78
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 36
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical class OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 claims description 20
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 238000010898 silica gel chromatography Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- 235000019253 formic acid Nutrition 0.000 claims description 8
- 241000221638 Morchella Species 0.000 claims description 7
- 238000004809 thin layer chromatography Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 238000004440 column chromatography Methods 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 229920005654 Sephadex Polymers 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 5
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 3
- 239000000287 crude extract Substances 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 239000012916 chromogenic reagent Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000233866 Fungi Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000002447 crystallographic data Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- -1 pyrrolic acid compound Chemical class 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 1
- 238000005570 heteronuclear single quantum coherence Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明属于天然药物分离提取领域,具体涉及一种利用羊肚菌制备吡咯酸化合物的方法及其应用。具体制备方法为:以羊肚菌为原料,经固体发酵、产物有机浸提、分离纯化得到吡咯酸化合物。所用的羊肚菌原料为羊肚菌M.co 0010(Morehella esculenta),已于2014年7月6日保藏于中国武汉武汉大学中国典型培养物保藏中心,保藏编号为CCTCC M 2014324。根据该制备方法得到了一种吡咯酸化合物,实验证明该吡咯酸化合物具有抗氧化活性,可以用于制备抗氧化药物。本发明制备的吡咯酸化合物有较好的抗氧化活性,可以利用菌株Morehella esculenta发酵制得,培养基原料来源广泛,制备方法简单,容易实现工业化生产。The invention belongs to the field of separation and extraction of natural medicines, and in particular relates to a method for preparing pyrrole acid compounds by using morels and an application thereof. The specific preparation method is as follows: taking hickory chick as a raw material, obtaining the pyrrole acid compound through solid fermentation, organic extraction of the product, separation and purification. The raw material of morel used is morehella esculenta M.co 0010 (Morehella esculenta), which has been preserved in the Chinese Type Culture Collection Center of Wuhan University, Wuhan, China on July 6, 2014, with the preservation number CCTCC M 2014324. According to the preparation method, a pyrrole acid compound is obtained, and experiments prove that the pyrrole acid compound has antioxidant activity and can be used to prepare antioxidant drugs. The pyrrole acid compound prepared by the invention has good antioxidant activity, can be prepared by fermentation of the strain Morehella esculenta , has wide sources of culture medium raw materials, simple preparation method, and is easy to realize industrialized production.
Description
技术领域technical field
本发明属于天然药物分离提取领域,具体涉及一种利用羊肚菌制备吡咯酸化合物的方法及其应用。The invention belongs to the field of separation and extraction of natural medicines, and in particular relates to a method for preparing pyrrole acid compounds by using morels and an application thereof.
背景技术Background technique
天然抗氧化物质具有清除自由基,进而具有抗衰老和预防各种疾病的作用。食药用大型真菌不但富含氨基酸、维生素、多糖、蛋白质等营养物质,而且其次级代谢产物结构类型多样,这些次级代谢具有抗氧化、抗细菌、促进神经生长因子合成、酶抑制剂、抗真菌、细胞毒、受体拮抗剂等多种生物活性。抗氧化功能是食药用菌的重要功能之一,从食药用菌中分离提取天然抗氧化物质,有助于食药用菌资源的开发利用,丰富了天然药物资源,促进人类健康发展与疾病预防。基于以上背景,开展本发明的研究。Natural antioxidant substances can scavenge free radicals, and then have the effect of anti-aging and preventing various diseases. Edible and medicinal macrofungi are not only rich in nutrients such as amino acids, vitamins, polysaccharides, and proteins, but also have various types of secondary metabolites. Fungal, cytotoxic, receptor antagonist and other biological activities. Antioxidant function is one of the important functions of edible and medicinal fungi. The isolation and extraction of natural antioxidant substances from edible and medicinal fungi will help the development and utilization of edible and medicinal fungus resources, enrich natural drug resources, and promote human health and development. prevent disease. Based on the above background, carry out research of the present invention.
发明内容Contents of the invention
本发明的目的在于针对食用菌中含有丰富的天然抗氧化物质,但开发利用程度低;提供一种利用羊肚菌制备吡咯酸化合物的方法及其应用。本发明制备的吡咯酸化合物有较好的抗氧化活性,且培养基原料来源广泛,制备方法简单,容易实现工业化生产。The purpose of the present invention is to provide a method for preparing pyrrole acid compounds by using Morchella fungus and its application against the fact that edible fungi are rich in natural antioxidant substances, but the degree of development and utilization is low. The pyrrole acid compound prepared by the invention has better antioxidant activity, and the source of culture medium raw materials is wide, the preparation method is simple, and industrial production can be easily realized.
为实现上述目的,本发明采用如下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一种羊肚菌,所述菌种为羊肚菌M.co 0010(Morehella esculenta),已于2014年7月6日保藏于中国 武汉 武汉大学 中国典型培养物保藏中心,保藏编号为CCTCC M2014324。Morehella esculenta, the strain of which is M.co 0010 (Morehella esculenta), has been preserved in the Chinese Type Culture Collection Center of Wuhan University, Wuhan, China on July 6, 2014, and the preservation number is CCTCC M2014324.
一种利用羊肚菌制备吡咯酸化合物的方法,以羊肚菌为原料,经固体发酵、产物有机浸提、分离纯化得到吡咯酸化合物。The invention discloses a method for preparing pyrrolic acid compounds by using morels. The morels are used as raw materials to obtain the pyrrolic acid compounds through solid fermentation, organic extraction of products, and separation and purification.
所述的利用羊肚菌制备吡咯酸化合物的方法,包括以下步骤:The method for preparing the pyrrole acid compound by using Morchella, comprises the following steps:
(1)固体发酵:将羊肚菌活化后进行固体发酵;然后进行培养;(1) Solid fermentation: activate morels and carry out solid fermentation; then culture;
(2)产物有机浸提:将步骤(1)培养得到的菌丝体与培养基用有机溶剂浸提;浸提液浓缩后,用等体积的乙酸乙酯和水进行萃取;取乙酸乙酯相,经脱水、浓缩后,得到有机粗提物浸膏;(2) Organic extraction of the product: extract the mycelia and culture medium obtained in step (1) with an organic solvent; after the extraction solution is concentrated, extract it with an equal volume of ethyl acetate and water; take ethyl acetate phase, after dehydration and concentration, the organic crude extract extract is obtained;
(3)分离纯化:将有机粗提物浸膏用甲醇溶解后,进行凝胶柱层析;采用薄层层析-生物自显影法(参考文献:谷丽华等.应用薄层色谱-生物自显影技术评价乌药等三种中药的抗氧化活性. 药学学报. 2006,41(10):956-962)检测各组分的抗氧化活性,将具有抗氧化活性的组分收集、合并后,再进行反相硅胶柱层析,收集具有抗氧化活性的组分;最后再利用正相硅胶柱层析,得到具有抗氧化活性的吡咯酸化合物。(3) Separation and purification: After dissolving the crude organic extract extract in methanol, perform gel column chromatography; use thin-layer chromatography-bioautographic method (reference: Gu Lihua et al. The development technique was used to evaluate the antioxidant activity of three traditional Chinese medicines such as Wuyao. Acta Pharmaceutica Sinica. 2006, 41(10):956-962) to detect the antioxidant activity of each component, and after the components with antioxidant activity were collected and combined, Reverse-phase silica gel column chromatography is then performed to collect components with antioxidant activity; finally, normal-phase silica gel column chromatography is used to obtain the pyrrolic acid compound with antioxidant activity.
步骤(1)所述的培养其条件固体发酵的培养基配方组成为:马铃薯16-25wt%,葡萄糖1.5-2.5wt%,蛋白胨0.5-1.5wt%,1-2wt%琼脂,余量为水;自然pH,0.1 Mpa、100~140℃灭菌15~40 min,于25-28 ℃恒温培养25-35天。The culture medium formula of the conditional solid fermentation described in step (1) consists of: potato 16-25wt%, glucose 1.5-2.5wt%, peptone 0.5-1.5wt%, 1-2wt% agar, and the balance is water; Natural pH, 0.1 Mpa, sterilized at 100-140°C for 15-40 minutes, and cultured at 25-28°C for 25-35 days.
步骤(2)所述的有机溶剂为乙酸乙酯、甲醇、丙酮、冰乙酸中的一种或多种。The organic solvent described in step (2) is one or more of ethyl acetate, methanol, acetone, and glacial acetic acid.
步骤(3)所述的凝胶柱层析其参数为:Sephadex LH-20葡聚糖凝胶柱,甲醇洗脱,流速为12 s/滴,每管收集5-10mL,每试管取样进行薄层层析:展开剂为氯仿:甲醇=10:1,显色剂为10wt%的硫酸乙醇,相似组分进行合并。The parameters of the gel column chromatography described in step (3) are: Sephadex LH-20 dextran gel column, eluted with methanol, the flow rate is 12 s/drop, 5-10mL is collected in each tube, and each tube is sampled for thin Layer chromatography: The developing agent is chloroform:methanol=10:1, the color developing agent is 10wt% ethanol sulfate, and similar components are combined.
步骤(3)所述的反相硅胶柱层析其洗脱为:用甲醇与水的混合液作为洗脱剂,甲醇占混合液体积的5-30%,混合液中含有体积分数为0.1-1% 的甲酸,进行梯度洗脱;所述的正相硅胶柱层析其洗脱为:用氯仿与甲醇的混合液作为洗脱剂,体积比为40:1-120:1,洗脱剂中含有体积分数为0.1-2‰的甲酸。The elution of the reversed-phase silica gel column chromatography described in step (3) is: use a mixture of methanol and water as the eluent, methanol accounts for 5-30% of the volume of the mixture, and the mixture contains a volume fraction of 0.1- 1% formic acid for gradient elution; the elution of the normal phase silica gel column chromatography is as follows: use a mixture of chloroform and methanol as the eluent, the volume ratio is 40:1-120:1, the eluent Contains formic acid with a volume fraction of 0.1-2‰.
一种如上所述的方法得到的吡咯酸化合物,其分子式为C5H5NO2,结构式为:A kind of pyrrole acid compound obtained by the above method, its molecular formula is C 5 H 5 NO 2 , and its structural formula is:
。 .
所述的吡咯酸化合物的应用,具体为:用于制备抗氧化药物。The application of the pyrrole acid compound is specifically: for the preparation of antioxidant drugs.
本发明的有益效果在于:The beneficial effects of the present invention are:
本发明制备的吡咯酸化合物有较好的抗氧化活性,可以利用菌株Morehella esculenta发酵制得,培养基原料来源广泛,制备方法简单,容易实现工业化生产。The pyrrole acid compound prepared by the invention has good antioxidant activity, can be prepared by fermentation of the strain Morehella esculenta , has wide sources of culture medium raw materials, simple preparation method, and is easy to realize industrialized production.
附图说明Description of drawings
图1化合物吡咯-2-羧酸的薄层色谱图;1表示对照维生素C,2表示化合物吡咯-2-羧酸。Fig. 1 is the thin-layer chromatogram of compound pyrrole-2-carboxylic acid; 1 represents the control vitamin C, and 2 represents compound pyrrole-2-carboxylic acid.
具体实施方式Detailed ways
本发明用下列实施例来进一步说明本发明,但本发明的保护范围并不限于下列实施例。The present invention further illustrates the present invention with following examples, but protection scope of the present invention is not limited to following examples.
本发明提供的吡咯酸化合物的的制备方法,其步骤为:The preparation method of pyrrole acid compound provided by the invention, its steps are:
1)固体发酵及产物有机浸提:将羊肚菌(Morehella esculenta)斜面菌种先在培养平板上活化,培养温度26 ℃,培养时间10天,再进行大批量的固体发酵,采用培养基配方为:每升水中含马铃薯200 g,葡萄糖20 g,蛋白胨10 g,琼脂10 g,pH自然,0.1 Mpa,100~140℃灭菌15~40 min,置于25-28℃恒温培养。发酵25-35天后,用离心法将菌丝体与发酵液分离。培养后菌丝体与培养基用乙酸乙酯、甲醇、丙酮等有机溶剂浸提。浸提液浓缩后用乙酸乙酯与水等体积萃取,乙酸乙酯相脱水后浓缩,得到有机粗提物浸膏。1) Solid fermentation and organic extraction of products: first activate Morehella esculenta slant strains on a culture plate, culture temperature 26 ℃, culture time 10 days, and then carry out large-scale solid fermentation, using the culture medium formula Contains 200 g of potatoes, 20 g of glucose, 10 g of peptone, 10 g of agar per liter of water, natural pH, 0.1 Mpa, sterilized at 100-140°C for 15-40 min, and cultured at a constant temperature of 25-28°C. After 25-35 days of fermentation, the mycelium is separated from the fermentation broth by centrifugation. After cultivation, the mycelia and medium are extracted with organic solvents such as ethyl acetate, methanol, and acetone. The extract is concentrated and extracted with equal volumes of ethyl acetate and water, and the ethyl acetate phase is dehydrated and then concentrated to obtain the crude organic extract.
2)分离提纯:将1) 所述的有机粗提物浸膏用甲醇溶解,Sephadex LH-20葡聚糖凝胶柱层析,甲醇洗脱,流速约为12 s/滴,每管收集5-10 mL。采用薄层层析-生物自显影法检测每管的抗氧化活性,合并具有活性的组分,用甲醇溶解,进行反相硅胶柱层析,用含有体积分数为0.1-1% 甲酸的甲醇与水的混合液作为洗脱剂,甲醇占混合液体积的5-30%,进行梯度洗脱,分管收集,合并抗氧化活性的组分;最后利用正相硅胶层析,用含有体积分数为0.1-2‰甲酸的氯仿与甲醇的混合液作为洗脱剂,体积比为40:1-120:1,得到具有抗氧化活性的吡咯酸化合物纯品。2) Separation and purification: dissolve the crude organic extract described in 1) with methanol, perform Sephadex LH-20 dextran gel column chromatography, elute with methanol, the flow rate is about 12 s/drop, and collect 5 -10 mL. The antioxidant activity of each tube was detected by thin-layer chromatography-bioautographic method, and the active components were combined, dissolved in methanol, and subjected to reverse-phase silica gel column chromatography, with methanol containing 0.1-1% formic acid and The mixed solution of water is used as the eluent, methanol accounts for 5-30% of the volume of the mixed solution, gradient elution is performed, collected in separate tubes, and the components with antioxidant activity are combined; finally, normal phase silica gel chromatography is used, with a volume fraction of 0.1 -2‰ formic acid mixed solution of chloroform and methanol is used as eluent, the volume ratio is 40:1-120:1, and the pure product of pyrrole acid compound with antioxidant activity is obtained.
对纯品进行X射线单晶衍射和核磁共振分析,并进行抗氧化活性测试。The pure product was analyzed by X-ray single crystal diffraction and nuclear magnetic resonance, and the antioxidant activity was tested.
根据X射线单晶衍射和核磁共振数据,对化合物进行结构鉴定,可确定化合物的结构。According to X-ray single crystal diffraction and nuclear magnetic resonance data, the structure of the compound is identified, and the structure of the compound can be determined.
本发明所述的化合物为吡咯酸化合物吡咯-2-羧酸,分子式为C5H5NO2,结构式如下:The compound described in the present invention is pyrrole acid compound pyrrole-2-carboxylic acid, the molecular formula is C 5 H 5 NO 2 , and the structural formula is as follows:
。 .
根据化合物吡咯-2-羧酸的抗氧化活性测定,发现吡咯-2-羧酸具有较强的抗氧化活性(实施例3)。According to the determination of the antioxidant activity of the compound pyrrole-2-carboxylic acid, it was found that pyrrole-2-carboxylic acid has strong antioxidant activity (Example 3).
实施例1Example 1
用马铃薯葡萄糖固体培养基(每升水中含马铃薯200 g,葡萄糖20 g,蛋白胨10 g,琼脂10 g,pH自然,0.1 MPa,121 ℃灭菌30 min),将活化后的菌株Morehella esculenta固体培养9.6 L,于26 ℃摇床培养30 d。培养后菌丝体与培养基用乙酸乙酯:甲醇:冰乙酸体积比为80:15:5的有机溶剂浸提。浸提液浓缩后用乙酸乙酯与水等体积萃取,乙酸乙酯相脱水后浓缩,得甲醇可溶粗提物(1.54 g,褐色浸膏)。The activated strain Morehella esculenta was cultured on solid medium with potato dextrose (200 g potato, 20 g glucose, 10 g peptone, 10 g agar per liter of water, natural pH, 0.1 MPa, sterilized at 121 °C for 30 min). 9.6 L, cultured on a shaker at 26 °C for 30 days. After cultivation, the mycelia and the culture medium are extracted with an organic solvent with a volume ratio of ethyl acetate:methanol:glacial acetic acid of 80:15:5. The extract was concentrated and extracted with equal volumes of ethyl acetate and water, and the ethyl acetate phase was dehydrated and concentrated to obtain methanol-soluble crude extract (1.54 g, brown extract).
将上一步骤中1.54 g甲醇粗提物,用适量甲醇充分溶解,进行Sephadex LH-20葡聚糖凝胶柱层析,甲醇洗脱,流速约为12 s/滴,每管收集5mL,每试管取样进行薄层层析(展开剂为氯仿:甲醇=10:1,显色剂:10%硫酸乙醇)分析,相似组分合并,得到A(29.5 mg)、B(115.7 mg)、C(38.9 mg)、D(26.1 mg)、E(1013.9 mg)和F(240.4 mg)组分。采用薄层层析-生物自显影法检测每组分的抗氧化活性,获得具有抗氧化活性的组分F(240.4 mg)。对组分F进行反相硅胶柱(30 g)层析,用400 ml 30%甲醇水洗脱得到F1.1(16.7 mg)和F1.2(11.7mg)。组分F1.1再利用Sephadex LH-20葡聚糖凝胶柱层,用含1‰甲酸的丙酮洗脱,流速约为12 s/滴,每管收集2.5 mL,获得F1.1.1(8 mg)。组分F1.1.1最后利用正相硅胶层析80 ml氯仿-甲醇(80:1,氯仿中含1‰甲酸)洗脱得到所述的具有抗氧化活性的化合物纯品(1.5mg)。Dissolve 1.54 g of the crude methanol extract in the previous step with an appropriate amount of methanol, perform Sephadex LH-20 Sephadex column chromatography, and elute with methanol at a flow rate of about 12 s/drop. Test tube samples were taken for thin layer chromatography (developing solvent: chloroform:methanol=10:1, chromogenic agent: 10% sulfuric acid ethanol) analysis, similar components were combined to obtain A (29.5 mg), B (115.7 mg), C ( 38.9 mg), D (26.1 mg), E (1013.9 mg) and F (240.4 mg) components. The antioxidant activity of each component was detected by TLC-bioautographic method, and the component F (240.4 mg) with antioxidant activity was obtained. Fraction F was subjected to reverse-phase silica gel column (30 g) chromatography and eluted with 400 ml of 30% methanol water to obtain F1.1 (16.7 mg) and F1.2 (11.7 mg). Component F1.1 was then eluted with Sephadex LH-20 sephadex column layer with acetone containing 1‰ formic acid, the flow rate was about 12 s/drop, and 2.5 mL was collected in each tube to obtain F1.1.1 (8 mg ). Component F1.1.1 was finally eluted by normal phase silica gel chromatography with 80 ml of chloroform-methanol (80:1, containing 1‰ formic acid in chloroform) to obtain the pure compound (1.5 mg) with antioxidant activity.
化合物的结构确定可采用X射线单晶衍射的方法。根据所述化合物的X射线单晶衍射数据,可确定所述化合物的结构。The structure of the compound can be determined by X-ray single crystal diffraction method. According to the X-ray single crystal diffraction data of the compound, the structure of the compound can be determined.
所述化合物的X射线单晶衍射数据:单斜日晶系,晶体大小:0.7×0.7×0.4 mm,空间群为C 2/c,晶胞参数:a=13.2599 (14) ×10-10 m,b= 5.0253(5) ×10-10 m,c =14.8921(16) ×10-10 m,α=90°,β=99.199(11) °,γ=90°,V =979.57(18) ×10-30 m3,Z =4,Dc = 1.507 g∙cm-3,μ(MoKα) = 0.119㎜-1,由直接法解出,用最小二乘法精修,所述化合物的结构得以确定。X-ray single crystal diffraction data of the compound: monoclinic heliotropic system, crystal size: 0.7×0.7×0.4 mm, space group C 2/c, unit cell parameter: a =13.2599 (14)×10 -10 m , b = 5.0253(5) ×10 -10 m, c =14.8921(16) ×10 -10 m, α=90°, β=99.199(11) °, γ=90°, V =979.57(18) × 10 -30 m 3 , Z =4, Dc = 1.507 g∙cm -3 , μ (Mo K α) = 0.119㎜ -1 , solved by direct method and refined by least square method, the structure of the compound is obtained Sure.
实施例2Example 2
与实施例1类似,其区别在于化学结构鉴定采用核磁共振波谱(1H-NMR、13C-NMR、HSQC、HMBC、1H,1H-COSY)的解析方法,根据NMR数据可确定化合物的结构。Similar to Example 1, the difference is that the chemical structure identification adopts the analysis method of nuclear magnetic resonance ( 1 H-NMR, 13 C-NMR, HSQC, HMBC, 1 H, 1 H-COSY), and the identity of the compound can be determined according to the NMR data. structure.
所述化合物的1H NMR [500 MHz,(CD3)2CO]:δ 6.85 (m, 1H, H-3),δ 6.21 (m,1H, H-4), δ 7.05 (m, 1H, H-5)。所述化合物的13C NMR [500 MHz,(CD3)2OD]:δ 124.0(s,C-2), δ 115.8 (d, C-3), δ 110.4 (d,C-4), δ 124.1 (d, C-5), δ 162.0 (s, C-6)。从化合物的1H-NMR和13C-NMR的化学位移值表明化合物中含有单取代的吡咯结构单元。另据13C-NMR化学位移值δ162.0 s推测其为连在吡咯环2号位的羧基。 1 H NMR [500 MHz, (CD 3 ) 2 CO] of the compound: δ 6.85 (m, 1H, H-3), δ 6.21 (m, 1H, H-4), δ 7.05 (m, 1H, H-5). 13 C NMR [500 MHz, (CD 3 ) 2 OD] of the compound: δ 124.0(s,C-2), δ 115.8 (d, C-3), δ 110.4 (d,C-4), δ 124.1 (d, C-5), δ 162.0 (s, C-6). The chemical shift values of 1 H-NMR and 13 C-NMR of the compound indicate that the compound contains a monosubstituted pyrrole structural unit. According to the 13 C-NMR chemical shift value δ162.0 s, it is presumed that it is the carboxyl group attached to the 2-position of the pyrrole ring.
实施例3Example 3
采用薄层层析-生物自显影法(参考文献:谷丽华, 等. 应用薄层色谱-生物自显影技术评价乌药等三种中药的抗氧化活性. 药学学报. 2006, 41(10):956-962.)研究化合物的抗氧化活性。将所述的化合物1H-吡咯-2-羧酸和维生素C配制成2mg/ mL,取2 μL点样于薄层层析板,进行薄层层析(展开剂为氯仿:甲醇=10:1),展开后的薄层板喷以0.04%DPPH(1,1-二苯基-2-三硝基苯肼)乙醇溶液,于40 ℃下加热30 min,与阳性对照维生素C类似,所述的化合物在蓝色薄层板上相应位置上也显白色斑点。结果表明所述的化合物吡咯-2-羧酸具有抗氧化活性(图1),可以用于制备抗氧化药物。Using thin-layer chromatography-bioautoradiography (reference: Gu Lihua, et al. Application of thin-layer chromatography-bioautoradiography to evaluate the antioxidant activity of three traditional Chinese medicines such as black medicine. Acta Pharmaceutica Sinica. 2006, 41(10): 956-962.) to study the antioxidant activity of compounds. The compound 1H-pyrrole-2-carboxylic acid and vitamin C were formulated to 2 mg/mL, and 2 μL was spotted on a thin-layer chromatography plate for thin-layer chromatography (developing agent: chloroform:methanol=10:1 ), the developed TLC plate was sprayed with 0.04% DPPH (1,1-diphenyl-2-trinitrophenylhydrazine) ethanol solution, heated at 40 °C for 30 min, similar to the positive control vitamin C, the The compound also showed white spots on the corresponding position on the blue TLC plate. The results show that the compound pyrrole-2-carboxylic acid has antioxidant activity (Figure 1), and can be used to prepare antioxidant drugs.
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。The above descriptions are only preferred embodiments of the present invention, and all equivalent changes and modifications made according to the scope of the patent application of the present invention shall fall within the scope of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410679109.2A CN104450818B (en) | 2014-11-24 | 2014-11-24 | A kind of method and its application that pyrroles's acid compound is prepared using hickory chick |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410679109.2A CN104450818B (en) | 2014-11-24 | 2014-11-24 | A kind of method and its application that pyrroles's acid compound is prepared using hickory chick |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104450818A CN104450818A (en) | 2015-03-25 |
CN104450818B true CN104450818B (en) | 2018-05-04 |
Family
ID=52897564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410679109.2A Active CN104450818B (en) | 2014-11-24 | 2014-11-24 | A kind of method and its application that pyrroles's acid compound is prepared using hickory chick |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104450818B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115154490B (en) * | 2022-07-22 | 2023-11-21 | 四川省食用菌研究所 | Antibacterial active parts of morel fruiting body and preparation method thereof |
-
2014
- 2014-11-24 CN CN201410679109.2A patent/CN104450818B/en active Active
Non-Patent Citations (3)
Title |
---|
3种食用菌活性物质的分离纯化及结构分析;吴小君;《中国优秀硕士学位论文全文数据库农业科技辑》;20140815;第5页第1段,第6页第1段,第9页第3段,第12页第1.5节,第15页第2.4.3节,第43页第1.3节,第44-45页2.1-2.2,3.2节,第48页第3.4.3节 * |
应用薄层色谱-生物自显影技术评价乌药等三种中药的抗氧化性;谷丽华等;《药学学报》;20061231;第41卷(第10期);956-962 * |
洋来源放线菌无活性野生株的链霉素抗性抗肿瘤活性突变株新产代谢产物研究;孙玉雯等;《军事医学科学院院刊》;20100430;第34卷(第2期);摘要,第121页图1 * |
Also Published As
Publication number | Publication date |
---|---|
CN104450818A (en) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9950021B2 (en) | Anti-cancer active substance from Antrodia camphorata, method for preparing the same and use thereof | |
CN103910708B (en) | The Azaphilones compound in a kind of thalassiomycetes source and its preparation method and application | |
CN102443613B (en) | Antrodia camphorata anti-cancer active substance and preparation method and application thereof | |
CN104592082B (en) | Preparation method and application of penicillol D2 derived from Penicillium citrinum | |
CN110283053A (en) | A kind of symbiotic effects monomeric compound quick separating preparation method and application | |
CN107686816A (en) | A kind of pillworm fungal component Chaetomium globosum and its application in antitumoral compounds are prepared | |
CN103910701B (en) | The naphthoquinone compound in a kind of thalassiomycetes source and its preparation method and application | |
CN104450818B (en) | A kind of method and its application that pyrroles's acid compound is prepared using hickory chick | |
CN103911407A (en) | Marine fungus-derived Azaphilone dimer compound, and preparation method and application thereof | |
CN112358516A (en) | Application of diosmetin (4-O-methyl) glucoside compound in preparation of lipid-lowering drugs | |
CN107739362B (en) | Derived from aspergillus versicolor anthraquinone analog compound and prepare the application of anti-human oesophagus cancer drug | |
CN107739361B (en) | Derived from aspergillus versicolor anthraquinone analog compound and prepare the application of anti-human colon cancer drug | |
CN106083556A (en) | Azulene structure noval chemical compound and extraction separation method thereof in Herba Portulacae | |
CN105274152B (en) | Biotransformation method, product and application of curcumin | |
CN108703972A (en) | A kind of flavones-application of the saponin(e meroterpenoids compound in medicine preparation | |
CN115584330A (en) | Nocardiopsis, compound Novofuran and preparation method and application thereof | |
CN115385878A (en) | Natural active compound norofuran, and preparation method and application thereof | |
CN120098804B (en) | Fungus and preparation method thereof Demethylincisterol A and acute liver injury medicine | |
CN104447475B (en) | Preparation method and application of penicillenol D1 derived from penicillium citrinum | |
CN103073550B (en) | The isolation technique of ring (L-PROLINE-Valine) in Phellinus bacterium | |
CN102584547A (en) | Bisabolane sesquiterpene dimer compound as well as preparation method and application thereof | |
CN106420715B (en) | Mould enol E1 derived from tangerine green trichoderma is in the application for preparing anti-lymphadenoma drug | |
CN108640896B (en) | A kind of Desertorin B and its extraction method and application | |
CN106631803B (en) | A kind of chloroanthraquinone compound in mangrove fungi source and its application as antibacterial agent | |
CN106011190B (en) | Preparation method of natural p-aminobenzoic acid and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210611 Address after: 362417 No.17, Tianshou Fudi Road, kangsui village, Taozhou Township, Anxi County, Quanzhou City, Fujian Province Patentee after: ANXI TAOYUAN ORGANIC TEA FARM Co.,Ltd. Address before: 350117 Qishan campus of Fujian Normal University, Fuzhou University Town, Fujian Province Patentee before: Fujian Normal University |
|
TR01 | Transfer of patent right |